Sequential Therapy in Multiple Myeloma Guided by MRD Assessments — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama Colorado Blood Cancer Institute, Denver, Colorado Columbia University, New York, New York Oregon Health and Science University, Portland, Oregon Vanderbilt University, Nashville, Tennessee University of Texas Southwestern, Dallas, Texas University of Utah, Salt Lake City, Utah University of Washington, Seattle, Washington University of Wisconsin - Carbone, Madison, Wisconsin Medical College of Wisconsin, Milwaukee, Wisconsin Age range
18 Years and older
Last updated January 2026